Feature Channels: Diabetes

Filters close
Released: 9-Sep-2021 1:10 PM EDT
Um transplante de pâncreas pode curar a diabetes: especialista da Mayo Clinic explica
Mayo Clinic

Muitos avanços foram feitos em relação aos tratamentos da diabetes ao longo da década passada. A diabetes é uma doença crônica com cuidados necessários por toda a vida, com potencial para complicações significativas. Apesar dos avanços, muitas pessoas com diabetes lutam contra a doença.

Released: 9-Sep-2021 1:05 PM EDT
El trasplante de páncreas cura la diabetes: explicación de un experto de Mayo Clinic
Mayo Clinic

El tratamiento de la diabetes ha avanzado mucho en la última década. La diabetes es una enfermedad crónica que dura toda la vida y causa complicaciones importantes. Pese a los avances, muchas personas diabéticas tienen problemas.

Newswise: Find Mothers’ Diabetes May Induce Premature Aging of Neural Tissue in Early Development of Fetuses, Leading to Birth Defects
Released: 9-Sep-2021 12:55 PM EDT
Find Mothers’ Diabetes May Induce Premature Aging of Neural Tissue in Early Development of Fetuses, Leading to Birth Defects
University of Maryland School of Medicine

About 300,000 to 400,000 fetuses per year from mothers with diabetes develop neural tube defects—when the tissue that eventually forms the brain and spinal cord fails to form properly—which can lead to miscarriage or profound disability.

Released: 8-Sep-2021 1:10 PM EDT
Sharp fall in amputations due to type 1 diabetes
University of Gothenburg

Amputation in type 1 diabetes is becoming relatively less common in Sweden. The rate has fallen by just over 40 percent over an approximately 20-year period, a University of Gothenburg study shows.

Released: 7-Sep-2021 12:30 PM EDT
Study identifies potential target for treating systemic inflammation in obesity
University of Chicago Medical Center

Researchers studying the enzyme DHPS have determined that blocking its activity in mouse macrophages leads to a reduction in proteins that drive inflammation during obesity, leading to improved glycemic control.

Released: 2-Sep-2021 3:30 PM EDT
UC San Diego Health Launches New Center to Spur Patient-Centered Technologies
UC San Diego Health

From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.

Released: 2-Sep-2021 9:35 AM EDT
Society Creates Senior Level Position Dedicated to Membership and Diversity
Endocrine Society

As part of our commitment to diversity, equity, and inclusion (DEI), the Endocrine Society has established a new executive level role to focus on member value, engagement, and our DEI strategy.

Released: 31-Aug-2021 2:50 PM EDT
Two UAlbany Studies Find Links Between Neighborhood Risk and Birth Outcomes, and Maternal Depression and Gestational Diabetes
University at Albany, State University of New York

Two new studies released by the University at Albany School of Public Health shed light on different factors impacting the health of mothers and newborns, with one study finding a link between neighborhood risk and birth outcomes, and a second indicating a relationship between maternal depression and gestational diabetes.

Released: 31-Aug-2021 11:15 AM EDT
Oxygen-delivering hydrogel accelerates diabetic wound healing
Washington University in St. Louis

About one-fourth of people with diabetes develop painful foot ulcers, which are slow to heal due to low oxygen in the wound from impaired blood vessels and increased inflammation.

   
Released: 30-Aug-2021 4:10 PM EDT
Home Health Care Services Reduce Re-hospitalizations for Medicare Patients with Diabetes
Rutgers University-New Brunswick

Medicare patients with diabetes are more likely to be re-hospitalized if they do not receive recommended home health care within two days of discharge, according to a Rutgers study.

   
Released: 30-Aug-2021 9:05 AM EDT
International Experts Outline Diabetes Remission Diagnosis Criteria
Endocrine Society

People with type 2 diabetes should be considered in remission after sustaining normal blood sugar levels for three months or more, according to a new consensus statement from the Endocrine Society, the European Association for the Study of Diabetes, Diabetes UK and the American Diabetes Association published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Released: 27-Aug-2021 6:50 PM EDT
Reducing sugar in packaged foods can prevent disease in millions
Massachusetts General Hospital

Cutting 20% of sugar from packaged foods and 40% from beverages could prevent 2.48 million cardiovascular disease events

17-Aug-2021 8:00 AM EDT
How migraines protect against diabetes
American Chemical Society (ACS)

People who get migraines are less likely to develop type 2 diabetes. Today, scientists report the latest findings about the relationship between insulin production and the peptides that cause migraine pain. They will present their results at ACS Fall 2021.

   
Released: 25-Aug-2021 5:00 PM EDT
Treatment and Considerations for Pancreatic Cancer
Hackensack Meridian Health (Mountainside Medical Center)

We spoke with hematology oncologist James Orsini, Jr., M.D., to learn more about pancreatic cancer

Released: 23-Aug-2021 3:15 PM EDT
Making patient care easier: Self-powered diaper sensors that monitor urine sugar levels
Tokyo University of Science

Thanks to science and modern medicine, we know a lot more now about the early signs of certain diseases and which biomarkers to check.

   
Released: 19-Aug-2021 3:00 PM EDT
VIDEO AND TRANSCRIPT AVAILABLE: Breakthrough Cases and COVID Boosters: Live Expert Panel for August 18, 2021
Newswise

Expert Q&A: Do breakthrough cases mean we will soon need COVID boosters? The extremely contagious Delta variant continues to spread, prompting mask mandates, proof of vaccination, and other measures. Media invited to ask the experts about these and related topics.

Released: 19-Aug-2021 10:25 AM EDT
Skipping Simple Urine Test Leaves High-Risk Groups With Untreated Kidney Disease
Johns Hopkins Bloomberg School of Public Health

Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a simple test for protein in the urine to screen for this potentially deadly disorder.

Released: 17-Aug-2021 12:00 PM EDT
Benefits of time-restricted eating depend on age and sex
Salk Institute for Biological Studies

Time-restricted eating (TRE), a dietary regimen that restricts eating to specific hours, has garnered increased attention in weight-loss circles.

Released: 12-Aug-2021 10:05 AM EDT
Diabetes care and education specialists honored at Association of Diabetes Care & Education Specialists 2021 virtual conference
Association of Diabetes Care & Education Specialists (ADCES)

Diabetes care and education specialists were recognized at the virtual ADCES21 Annual Conference for their achievements in diabetes care and their dedication to the association.

Released: 11-Aug-2021 4:10 PM EDT
Do Some Diabetes Drugs Reduce the Risk of Alzheimer’s?
American Academy of Neurology (AAN)

MINNEAPOLIS – People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer’s disease, when compared to both people with type 2 diabetes not taking the drugs and people without diabetes. The new study, published in the August 11, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups.

Released: 10-Aug-2021 9:00 AM EDT
Research Gaps on ‘Rare’ Sugars that Show Promise as Alternative Sweeteners
Institute for the Advancement of Food and Nutrition Sciences

Uniquely metabolized sugars naturally present in small amounts in foods such as honey, maple syrup, and certain fruits are alternative sweeteners with potential health benefits. However, controlled trials are needed before their full benefits may be realized.

Released: 10-Aug-2021 7:00 AM EDT
Frequent Breaks from Sitting May Improve Daily Blood Sugar Fluctuations
American Physiological Society (APS)

Frequent activity breaks from sitting may improve fasting blood sugar (glucose) levels and stabilize daily fluctuations, according to new research. The study, the first of its length to explore the effects of activity breaks in “free-living” conditions, is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism. It was chosen as an APSselect article for August.

Released: 9-Aug-2021 11:05 AM EDT
New Diabetes Management Fellowship Recipient to Address Barriers to Continuous Glucose Monitoring Use in Adolescents and Families
Association of Diabetes Care & Education Specialists (ADCES)

The Association of Diabetes Care & Education Specialists Foundation and the Certification Board for Diabetes Care and Education are proud to award Kelsey Howard, Ph.D., a one-year fellowship in integrated diabetes management.

Released: 9-Aug-2021 8:30 AM EDT
Do Vitamin D Supplements Offer Kidney-Related Benefits for Individuals With High Diabetes Risk?
American Society of Nephrology (ASN)

• In a clinical trial of individuals at high risk for developing type 2 diabetes, which is the leading cause of kidney disease, vitamin D supplementation did not have significant effects on kidney health. • As participants were not selected according to baseline vitamin D levels, investigators cannot exclude a kidney benefit for individuals with vitamin D deficiency.

Released: 6-Aug-2021 8:05 AM EDT
An Overactive Sweet Tooth May Spell Trouble for Our Cellular Powerplants
Van Andel Institute

GRAND RAPIDS, Mich. (August 3, 2021) — The average American eats roughly 22 teaspoons of added sugar a day — more than three times the recommended amount for women and more than double the recommended amount for men.

Released: 4-Aug-2021 12:55 PM EDT
Most Comprehensive Review Yet of Keto Diets Finds Heart Risks, Cancer Risk, Dangers to Pregnant Women and Kidney Patients
Physicians Committee for Responsible Medicine

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Released: 4-Aug-2021 11:30 AM EDT
Artificial Pancreas Trialled for Outpatients with Type 2 Diabetes for First Time
University of Cambridge

An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis.

Released: 4-Aug-2021 11:25 AM EDT
Common Weight-Loss Drug Successfully Targets Fat That Can Endanger Heart Health
UT Southwestern Medical Center

DALLAS – August 4, 2021 – Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide. In adults who are overweight or have obesity combined with high cardiovascular risk, once-daily liraglutide combined with lifestyle interventions significantly lowered two types of fat that have been associated with risk to heart health: visceral fat and ectopic fat.

Released: 4-Aug-2021 11:05 AM EDT
Clinical Trial Shows Injectable Weight Loss Drug Directly Reduces Abdominal Fat
University Hospitals Cleveland Medical Center

A clinical trial found liraglutide, an injectable weight loss medication, reduced intra-abdominal and liver fat in participants more than placebo in addition to a low-calorie diet and increased physical activity.

Released: 3-Aug-2021 7:00 AM EDT
Low-fiber Diet May Lead to Gut Infection Even if You’re Not Overweight
American Physiological Society (APS)

Diet, more than body mass, may play a role in the risk for gut infection, and eating more fiber could be the key to prevention. The study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism.

Released: 30-Jul-2021 4:45 PM EDT
Medication Approved for Diabetes Being Tested for Treatment of Cocaine Use Disorder
University of Texas Health Science Center at Houston

With overdose rates involving cocaine soaring nearly 27% in 2020, researchers at The University of Texas Health Science Center at Houston (UTHealth) hope that a clinical trial combining a medication approved for the treatment of Type 2 diabetes with cognitive behavioral therapy (CBT) can help prevent relapse in cocaine use disorder patients.

Released: 29-Jul-2021 3:50 PM EDT
Wayne State Researcher Secures $2.3 Million in NIH Funding for Metabolic Research
Wayne State University Division of Research

A Wayne State University School of Medicine researcher has been awarded a $2.3 million grant by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, to support research in circadian RNA modification in metabolic disease.

Released: 27-Jul-2021 2:25 PM EDT
Structural Racism and Inequitable Pediatric Diabetes Care
University of Pennsylvania School of Nursing

Data show racial disparities in type 1 diabetes treatment and outcomes in non-Hispanic Black (NHB) children in the US. NHB children are less likely to be treated with diabetes technology, have poorer glycemic control and higher rates of diabetes complications and diabetes-related mortality than non-Hispanic white children. There is much to be done to ensure equitable care, but as yet, structural racism has not been a focus.

Released: 26-Jul-2021 6:05 PM EDT
Patients Report Long-Term Favorable Effects of Weight Loss Surgery in Their Daily Lives
Cleveland Clinic

A new analysis from the STAMPEDE trial shows that over the course of five years, patients who had bariatric and metabolic surgery to treat uncontrolled type 2 diabetes reported greater physical health, more energy, less body pain, and less negative effects of diabetes in their daily lives, compared with patients who had medical therapy alone for their diabetes. Long-term changes in psychosocial and emotional quality of life measures were not significantly different between the surgical and medical groups. The research was published in the Annals of Surgery.

Released: 26-Jul-2021 5:55 PM EDT
Hackensack Meridian Hackensack University Medical Center Earns Joint Commission Recertification for Advanced Diabetes Management
Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center has been recertified by the Joint Commission, a national accreditation organization, in Advanced Diabetes Management. This Disease Specific Certification demonstrates that Hackensack University Medical Center meets or exceeds national standards for diabetes care.

Released: 26-Jul-2021 11:10 AM EDT
No More Finger Pricks: A Continuous Glucose Monitor Benefits Patients with Diabetes in More Ways Than One
Michigan Medicine - University of Michigan

For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.

Released: 23-Jul-2021 5:15 PM EDT
New Biomarkers May Detect Early Eye Changes That Can Lead to Diabetes-Related Blindness
Indiana University

Optometry researchers have identified new biomarkers that may advance the early detection of diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in U.S. adults.

Released: 20-Jul-2021 3:10 PM EDT
Researchers Develop Novel Method for Glucagon Delivery
University of Notre Dame

In a new study, published in the Journal of the American Chemical Society, Matthew Webber, associate professor of chemical and biomolecular engineering, is rethinking the traditional use of glucagon as an emergency response by administering it as a preventive measure.

14-Jul-2021 6:05 AM EDT
Babies at Risk for Diabetes May Have Microbiota Restored
Rutgers University-New Brunswick

Newborns at risk for Type 1 diabetes because they were given antibiotics may have their gut microorganisms restored with a maternal fecal transplant, according to a Rutgers study.

Released: 20-Jul-2021 10:45 AM EDT
JDRF and the Association of Diabetes Care & Education Specialists Announce New Partnership
Association of Diabetes Care & Education Specialists (ADCES)

JDRF, the leading global funder of Type 1 diabetes research, and the Association of Diabetes Care & Education Specialists, the largest organization dedicated to diabetes care and education specialists, proudly announce a new partnership.

Released: 14-Jul-2021 9:30 AM EDT
Antidepressants May Improve Outcomes in People with Diabetes and Depression
Endocrine Society

People with diabetes and depression who take antidepressants may have a lower risk of death and of serious diabetes complications, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Released: 12-Jul-2021 1:05 PM EDT
American Thyroid Association Announces Award Recipients
American Thyroid Association

Esteemed clinicians and researchers recognized for their contributions to American Thyroid Association, thyroid cancer and thyroid disease research.

Released: 8-Jul-2021 10:15 AM EDT
Precision medicine helps identify “at-risk rapid decliners” in early-stage kidney disease
Michigan Medicine - University of Michigan

A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.

Released: 2-Jul-2021 8:05 AM EDT
University of Kentucky Study Finds Time-Restricted Eating May Reduce Diabetes-Related Hypertension
University of Kentucky

A new University of Kentucky College of Medicine study suggests that time-restricted eating may be able to help people with Type 2 diabetes reduce nocturnal hypertension, which is characterized by elevated blood pressure at night.

Released: 1-Jul-2021 5:20 PM EDT
Pesquisadores da Mayo Clinic exploram abordagem personalizada para medicamentos antiobesidade
Mayo Clinic

As iniciativas de medicina individualizada se concentram principalmente nas doenças raras ou no câncer. Pouco foi tentado para individualizar o tratamento de doenças crônicas não transmissíveis, como a obesidade, uma doença crônica recorrente e uma causa primária de diabetes tipo 2, gordura hepática, doenças cardiovasculares e câncer.

Released: 1-Jul-2021 5:05 PM EDT
Investigadores de Mayo Clinic exploran método personalizado para medicamentos contra la obesidad
Mayo Clinic

Las iniciativas de la medicina personalizada se concentran, principalmente, en las enfermedades raras o en el cáncer. Han sido escasos los intentos por personalizar el tratamiento de enfermedades crónicas no contagiosas, como la obesidad, que es una afección crónica y recurrente, además de causa principal para diabetes tipo 2, hepatopatía grasa, enfermedad cardiovascular y cáncer.

Released: 1-Jul-2021 11:15 AM EDT
Study: Antidiabetic Drug Causes Double the Weight Loss of Competitor in Type 2 Diabetes Patients
University at Buffalo

Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.

Released: 30-Jun-2021 5:55 PM EDT
A promising new pathway to treating type 2 diabetes
University of Arizona

This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that transformed Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, from a terminal disease into a manageable condition.



close
2.17359